Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a hormone-free contraceptive vaginal gel; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Frequently asked questions
What sector does Evofem Biosciences Inc (EVFM) operate in?
Evofem Biosciences Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Evofem Biosciences Inc (EVFM) current stock price?
As of the latest data, Evofem Biosciences Inc stock price is $0.01, with a previous close of $0.01.
What is Evofem Biosciences Inc (EVFM) current market capitalization?
Evofem Biosciences Inc market cap is approximately 927.71 thousand.
What is Evofem Biosciences Inc (EVFM) Earnings Per Share (EPS)?
The trailing EPS is -$0.11.
What is Evofem Biosciences Inc (EVFM) EBITDA?
Evofem Biosciences Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.44 million.
Does Evofem Biosciences Inc (EVFM) pay dividends?
No. Evofem Biosciences Inc does not pay a dividend.
What is Evofem Biosciences Inc (EVFM) beta (volatility) score?
Evofem Biosciences Inc has a beta of -1.356, indicating lower volatility than the overall market.